Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 2Gastrointestinal 1

Conditions

Stress Disorders, Post-Traumatic 1Pain 1Lung Neoplasms 1Digestive System Neoplasms 1Depression 1Colorectal Neoplasms 1Colonic Neoplasms 1Anxiety Disorders 1

Interventions

pembrolizumab 36Magnetic Resonance Spectroscopy 23Gemcitabine 19Specimen Handling 15Nivolumab 12Carboplatin 12Surveys and Questionnaires 11Paclitaxel 11Cetuximab 11Early Intervention, Educational 10Bevacizumab 10Standard of Care 9Cyclophosphamide 9Cisplatin 9Radiosurgery 8Methods 8Fluorouracil 8Docetaxel 8Blood Specimen Collection 8Psychiatric Rehabilitation 7Pemetrexed 7sargramostim 6aldesleukin 6Taxes 6Injections 6Fluorodeoxyglucose F18 6Educational Status 6Drug Therapy 6Biopsy 6Albumin-Bound Paclitaxel 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lung Neoplasms × Meditation × Gastrointestinal × Clear all
NCT01939210 2018-05-18

Meditation-Based Breathing Training in Improving Target Motion Management and Reducing Distress in Patients With Abdominal or Lung Cancer Undergoing Radiation Therapy

Albert Einstein College of Medicine

Phase NA Terminated
17 enrolled
GastrointestinalThoracic

Anxiety Disorders, Depression, Digestive System Neoplasms, Lung Neoplasms, Pain, Stress Disorders, Post-Traumatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡